Potential Benefits of BPC-157: What Does the Research Suggest
They act on entirely different systems: Lexapro is an SSRI that affects serotonin in the brain, while tirzepatide is a gut-hormone receptor agonist that affects appetite and blood sugar
[3] Based on data published to date including a Phase 2 obesity trial published in the New England Journal of Medicine (Jastreboff et al., 2023) and a Phase 2 type 2 diabetes trial published in The Lancet (Rosenstock et al., 2023) the most commonly reported side effects are gastrointestinal in nature
Zhang, R., Jiang, H., Liu, Y
It also blocks glucagon a hormone that raises blood sugar levels and slows digestion, helping your body release less glucose, or sugar, into your blood